Yeji Lee

Yeji Lee

Auto-generated profile, based on publicly available information

Yeji Lee

College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Biomaterials Research
Verified
Journal Article
Open access
YLYeji Lee
Yeji Lee
MJMichaela Jeong
Michaela Jeong
GLGyeongseok Lee
Gyeongseok Lee
JPJeongeun Park
Jeongeun Park
HJHyein Jung
Hyein Jung
HLHyukjin Lee
Hyukjin Lee
During the COVID-19 pandemic, mRNA vaccines emerged as a rapid and effective solution for global immunization. The success of COVID-19 mRNA vaccines has increased interest in the use of lipid nanoparticles (LNPs) for the in vivo delivery of mRNA therapeutics. Although mRNA exhibits robust expression profiles, transient protein expression is often observed, raising uncertainty regarding the frequency of its administration. Additionally, various RNA therapeutics may necessitate repeated dosing to achieve optimal therapeutic outcomes. Nevertheless, the impact of repeated administrations of mRNA/LNP on immune responses and protein expression efficacy remains unclear. In this study, we investigated the influence of the formulation parameters, specifically ionizable lipids and polyethylene glycol (PEG) lipids, on the repeat administration of mRNA/LNP. Our findings revealed that ionizable lipids had no discernible impact on the dose-responsive efficacy of repeat administrations, whereas the lipid structure and molar ratio of PEG lipids were primary factors that affected mRNA/LNP performance. The optimization of the LNP formulation with PEG lipid confirmed the sustained dose-responsive efficacy of mRNA after repeated administrations. This study highlights the critical importance of optimizing LNP formulations for mRNA therapeutics requiring repeated administrations.

31 July 2025 in Materials Today
Verified
Journal Article
Open access
YLYeji Lee
Yeji Lee
KGKaiyuan Guo
Kaiyuan Guo
MOMiyoung Oh
Miyoung Oh
EKEunbin Kim
Eunbin Kim
YJYujeong Jeong
Yujeong Jeong
HLHyukjin Lee
Hyukjin Lee

9 September 2015 in bioRxiv
Verified
Preprint
Open access
PDF file
XWXiaoquan Wen
Xiaoquan Wen
YLYeji Lee
Yeji Lee
FLFrancesca Luca
Francesca Luca
RPRoger Pique-Regi
Roger Pique-Regi
With the increasing availability of functional genomic data, 1–3 incorporating genomic annotations into genetic association analysis has become a standard procedure. However, the existing methods often lack rigor and/or computational efficiency and consequently do not maximize the utility of functional annotations. In this paper, we propose a rigorous inference procedure to perform integrative association analysis incorporating genomic annotations for both traditional GWAS and emerging molecular QTL mapping studies. In particular, we propose an algorithm, named “Deterministic Approximation of Posteriors” (DAP), which enables highly efficient and accurate joint enrichment analysis and identification of multiple causal variants. We use a series of simulation studies to highlight the power and computational efficiency of our proposed approach and further demonstrate it by analyzing the cross-population eQTL data from the GEUVADIS project and the multi-tissue eQTL data from the GTEx project. In particular, we find that genetic variants predicted to disrupt transcription factor binding sites are enriched in cis -eQTLs across all tissues. Moreover, the enrichment estimates obtained across the tissues are correlated with the cell types for which the annotations are derived.

9 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
YLYeji Lee
Yeji Lee
HJHan Jeong
Han Jeong
EKEunbin Kim
Eunbin Kim
YHYuna Hwang
Yuna Hwang
YBYongjoo Byeon
Yongjoo Byeon
HLHyukjin Lee
Hyukjin Lee
The broader clinical application of mRNA therapeutics remains constrained by dose-limiting toxicities, vector-associated immunogenicity, and prolonged tissue retention of lipid nanoparticles (LNPs) in vivo. Here, we report a class of ionizable lipids incorporating a sulfur-bearing hexyl 2-hydroxyethyl sulfide (HHES) motif that decouples mRNA delivery potency from these safety liabilities through dual functionality: the sulfur moiety acts as an intrinsic reactive oxygen species scavenger to suppress oxidative stress, while undergoing oxidative conversion into hydrophilic metabolites to promote rapid systemic clearance. HHES-based LNPs demonstrated a 3.3-fold shorter hepatic half-life and 29-fold lower total hepatic exposure than MC3, while maintaining robust protein expression including functional monoclonal antibody production in vivo. Repeated dosing in non-human primates confirmed negligible systemic, hepatic, or hematological toxicity. Leveraging this safety profile, subretinal HHES LNP delivery achieved up to 57% genome editing efficiency in retinal pigment epithelium, suppressing choroidal neovascularization by ~65% in a wet age-related macular degeneration model without structural damage or microglial activation. This dual-function design provides a generalizable framework for safe, transient, non-accumulative mRNA nanomedicines.

18 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
YLYeji Lee
Yeji Lee
YCYelim Choi
Yelim Choi
SKSeongryong Kim
Seongryong Kim
JYJinah Yeo
Jinah Yeo
JLJunghwa Lee
Junghwa Lee
HLHyukjin Lee
Hyukjin Lee
The global success of mRNA vaccines has underscored the pivotal role of lipid nanoparticles (LNPs), yet how subtle chemical variations in ionizable lipids and their formulation parameters orchestrate complex immune landscapes remains largely elusive. Here, we report a novel ionizable lipid, N4Z, and demonstrate that its distinct chemical signature selectively intensifies early innate immune programs compared to its structural analogue, N4Y. Single-cell transcriptomic profiling at the injection site reveals that N4Z-based LNPs uniquely prime inflammatory and type I interferon-related transcriptional programs, accompanied by a rapid influx of B and CD4 + T cells. Beyond lipid chemistry, we show that formulation-level tuning, that is independent of the ionizable lipid structure, can reshape the systemic biodistribution from hepatic dominance toward lymphoid tissues. This optimization substantially enhances macrophage-associated antigen expression, which in turn amplifies polyfunctional CD4 + T cell responses, T follicular helper cell differentiation, and germinal center reactions. Our findings establish that the coordinated interplay between lipid engineering and formulation design provides a programmable platform for precision mRNA vaccination, achieving superior protective efficacy and neutralizing activity over clinically validated benchmarks.